A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib
Trial details
- Registry ID
- NCT04633122
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With ImatinibNCT04633122 | Zai Lab (Shanghai) Co., Ltd. | Phase 2 | Completed | 2022-07-20Actual |
| (Peak) A Phase 3 Randomized Trial of Bezuclastinib (CGT9486)+Sunitinib vs. Sunitinib in Participants With Gastrointestinal Stromal TumorsNCT05208047 | COGT | Phase 3 | Recruiting | 2025-09-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |